Varner John Rodney
Known title: President & CEOCIK: 0001735543
Varner John Rodney's purchase track record
Varner John Rodney has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/21/2023 | GNPX | $20K | -22.4% | -72.0% | +2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| GNPX | ▼ Sell | Tax Withholding | 2,642 | $12K | 2/18/2024 | View on chart |
| GNPX | ▲ Buy | Open Market | 19,000 | $20K | 4/21/2023 | View on chart |
| GNPX | ▲ Buy | Grant | 625,000 | $0 | 2/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GNPX Among Top Movers in Monday After-Hours Session
Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.
GNPX Among Top Movers in Monday After-Hours Session. Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.